The question that travels hand in hand with these studies is who should start these drugs if they do prove to be effective? It’s not prudent to simply give the drugs to the whole aging population. We may soon have an answer to that question. A new study that shows differences in biological aging vs. chronological aging could help us find a way to differentiate between those for whom early treatment should be considered and those who aren’t likely to require the drugs.
Home About Subscribe Contact Resources/Supporting Sites Interviews Categories/Archives Purchase Book Ideal Client Testimonials